Aging, sleep, and kynurenic acid

衰老、睡眠和犬尿酸

基本信息

项目摘要

Advanced age presents challenges that increase the likelihood of poor quality and reduced duration of sleep. Disruptions in sleep that come with aging may result in effects such as fatigue, irritability, headaches, and deteriorating cognition. These disruptions are presumed to result from alterations in brain regions that underlie endocrine, behavioral and cognitive responses to homeostatic challenges in the organism. Unraveling common molecular mechanisms between aging and sleep disturbances – which may lead to new therapeutic strategies to alleviate these outcomes – is of great importance. Aging pathophysiology points to dysfunctional cholinergic transmission, which may be driven, in part, by altered hypothalamic orexin neurons. We hypothesize that kynurenic acid (KYNA), an endogenous antagonist of cholinergic neurotransmission, plays a mechanistic role in age-related sleep dysfunction and orexin activation. The small molecule KYNA is of particular interest because (i) KYNA and its synthesizing enzymes kynurenine aminotranferases (KATs) are increased in the aging brain and (ii) an excess of KYNA may be especially involved in sleep deficits that are seen with advanced age. We propose the novel hypothesis that accumulated KYNA activates orexin neurons, thereby disrupting sleep, a circumstance that is exacerbated with aging or a homeostatic sleep deprivation (SD) challenge wherein KYNA accumulates in the brain. A specific inhibitor of KAT II, main enzyme responsible for brain KYNA formation, will be used as an experimental tool to mechanistically test the hypothesis. There are two specific aims to test our hypothesis. Aim #1: To examine the relationship of KYNA to orexinergic activation in the lateral hypothalamus of young rats (3-4 months) and old rats (26-28 months). Hypothesis: Accumulation of KYNA, as a result of aging or acute sleep deprivation (SD), in the lateral hypothalamus activates orexin neurons. Aim #2: To evaluate the impact of KYNA synthesis inhibition in improving sleep quality in old rats and young rats with reduced orexin expression. Hypothesis: KAT II inhibition serves as an efficacious strategy to overcome sleep architecture deficits in old rats and young rats with reduced orexinergic signaling.
高龄带来的挑战增加了质量差的可能性, 睡眠时间。随着年龄的增长而出现的睡眠中断可能会导致疲劳, 易怒头痛和认知能力下降据推测,这些中断是由于 改变大脑区域的基础内分泌,行为和认知反应, 体内平衡的挑战。揭示了 衰老和睡眠障碍-这可能导致新的治疗策略,以减轻这些 结果-非常重要。衰老的病理生理学指向胆碱能功能障碍 这可能部分由改变的下丘脑食欲素神经元驱动。我们 假设犬尿烯酸(KYNA)是一种内源性胆碱能拮抗剂, 神经传递,在与年龄相关的睡眠功能障碍和食欲素中起着机械作用 activation.小分子KYNA是特别令人感兴趣的,因为(i)KYNA和其 合成酶犬尿氨酸氨基转移酶(KAT)在老化的大脑中增加, (ii)过量的KYNA可能特别涉及睡眠不足, 年龄我们提出了一个新的假设,即积累的KYNA激活食欲素神经元, 扰乱睡眠,这种情况会随着年龄的增长或缺乏稳态睡眠而加剧 (SD)其中KYNA在脑中积累的挑战。KAT II的特异性抑制剂,主要 负责大脑KYNA形成的酶,将被用作实验工具, 机械地检验假设。有两个具体的目的来检验我们的假设。目标一: 研究KYNA与下丘脑外侧区食欲素能激活的关系, 年轻大鼠(3-4个月)和老年大鼠(26-28个月)。假设:KYNA的蓄积,作为 由于老化或急性睡眠剥夺(SD),在外侧下丘脑激活食欲素 神经元目的#2:评估KYNA合成抑制对改善睡眠质量的影响 在老年大鼠和食欲素表达减少的年轻大鼠中。假设:KAT II抑制作用 一种有效的策略来克服老年大鼠和年轻大鼠的睡眠结构缺陷, 减少食欲素能信号传导。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ana Pocivavsek其他文献

Ana Pocivavsek的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ana Pocivavsek', 18)}}的其他基金

Kynurenic Acid, Sleep and Cognition
犬尿酸、睡眠和认知
  • 批准号:
    9912211
  • 财政年份:
    2018
  • 资助金额:
    $ 22.35万
  • 项目类别:
Kynurenic Acid, Sleep and Cognition
犬尿酸、睡眠和认知
  • 批准号:
    9362093
  • 财政年份:
    2017
  • 资助金额:
    $ 22.35万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.35万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了